Elanco Animal Health Operating Income 2016-2024 | ELAN

Elanco Animal Health annual/quarterly operating income history and growth rate from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Elanco Animal Health operating income for the quarter ending March 31, 2024 was $0.087B, a 51.93% decline year-over-year.
  • Elanco Animal Health operating income for the twelve months ending March 31, 2024 was $-0.937B, a 480.89% decline year-over-year.
  • Elanco Animal Health annual operating income for 2023 was $-0.843B, a 519.4% decline from 2022.
  • Elanco Animal Health annual operating income for 2022 was $0.201B, a 160.91% decline from 2021.
  • Elanco Animal Health annual operating income for 2021 was $-0.33B, a 53.19% decline from 2020.
Elanco Animal Health Annual Operating Income
(Millions of US $)
2023 $-843
2022 $201
2021 $-330
2020 $-705
2019 $185
2018 $185
2017 $-233
2016 $-25
2015 $-258
Elanco Animal Health Quarterly Operating Income
(Millions of US $)
2024-03-31 $87
2023-12-31 $-26
2023-09-30 $-1,016
2023-06-30 $18
2023-03-31 $181
2022-12-31 $-6
2022-09-30 $24
2022-06-30 $47
2022-03-31 $136
2021-12-31 $-73
2021-09-30 $-59
2021-06-30 $-179
2021-03-31 $-19
2020-12-31 $-278
2020-09-30 $-276
2020-06-30 $-100
2020-03-31 $-51
2019-12-31 $21
2019-09-30 $21
2019-06-30 $75
2019-03-31 $68
2018-12-31 $45
2018-09-30 $92
2018-06-30 $-31
2018-03-31 $79
2017-12-31
2017-09-30 $-11
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.068B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $15.637B 16.16
DaVita (DVA) United States $12.266B 15.23
Encompass Health (EHC) United States $8.515B 21.80
Chemed (CHE) United States $8.153B 25.27
Option Care Health (OPCH) United States $4.910B 18.59
RadNet (RDNT) United States $4.516B 94.05
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.226B 30.11
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.932B 27.64
U.S Physical Therapy (USPH) United States $1.433B 38.36
Pennant (PNTG) United States $0.697B 36.81
Aveanna Healthcare Holdings (AVAH) United States $0.483B 0.00
Atai Life Sciences (ATAI) Germany $0.221B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.018B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00